Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Annals of Neurology
|
May 29, 2015
Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome
Ruth Huizinga, Bianca van den Berg, Wouter van Rijs, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 7, 2019
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study
Christine Verboon, Bianca van den Berg, David R Cornblath, et al.
Brain : a Journal of Neurology
|
September 25, 2018
Regional variation of Guillain-Barré syndrome
Alex Y Doets, Christine Verboon, Bianca van den Berg, et al.
The Lancet. Neurology
|
March 20, 2021
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Christa Walgaard, Bart C Jacobs, Hester F Lingsma, et al.
Neurology
|
August 18, 2022
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort
Sonja E Leonhard, Annemiek A van der Eijk, Henning Andersen, et al.
Neurology
|
December 23, 2021
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score
Alex Y Doets, Hester F Lingsma, Christa Walgaard, et al.
Neurology
|
April 19, 2023
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome
Helle Al-Hakem, Alex Y Doets, Amro Maher Stino, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Annals of Neurology
|
May 29, 2015
Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome
Ruth Huizinga, Bianca van den Berg, Wouter van Rijs, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 7, 2019
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study
Christine Verboon, Bianca van den Berg, David R Cornblath, et al.
Brain : a Journal of Neurology
|
September 25, 2018
Regional variation of Guillain-Barré syndrome
Alex Y Doets, Christine Verboon, Bianca van den Berg, et al.
The Lancet. Neurology
|
March 20, 2021
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Christa Walgaard, Bart C Jacobs, Hester F Lingsma, et al.
Neurology
|
August 18, 2022
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort
Sonja E Leonhard, Annemiek A van der Eijk, Henning Andersen, et al.
Neurology
|
December 23, 2021
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score
Alex Y Doets, Hester F Lingsma, Christa Walgaard, et al.
Neurology
|
April 19, 2023
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome
Helle Al-Hakem, Alex Y Doets, Amro Maher Stino, et al.
Page
of 2